Business · 22/10/2020Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act of 1995
Summary
The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, related to the classification of over-the-counter drugs as Generally Recognized as Safe and Effective and Not Misbranded.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →